Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine

Clin Infect Dis. 1995 Feb;20(2):316-9. doi: 10.1093/clinids/20.2.316.

Abstract

This study compared the immune responses of healthy children to one or two doses of Oka/Merck varicella vaccine. Both cell-mediated and humoral immune responses were significantly stronger 1 year later among children given two doses 3 months apart than among those given a single dose. Long-term follow-up studies are needed to determine whether two doses of vaccine indeed provide more complete and more durable protection than a single dose against breakthrough varicella in healthy children.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / biosynthesis*
  • Chickenpox / immunology*
  • Chickenpox / prevention & control
  • Chickenpox Vaccine
  • Child
  • Child, Preschool
  • Female
  • Herpesvirus 3, Human / immunology*
  • Humans
  • Immunity, Cellular
  • Immunization Schedule
  • Infant
  • Lymphocyte Activation / immunology
  • Male
  • Vaccines, Attenuated / administration & dosage*
  • Vaccines, Attenuated / immunology
  • Viral Vaccines / administration & dosage*
  • Viral Vaccines / immunology

Substances

  • Antibodies, Viral
  • Chickenpox Vaccine
  • Vaccines, Attenuated
  • Viral Vaccines